| Literature DB >> 31700675 |
Rachel Matthews1, Meerat Kaur2, Catherine French3, Alison Baker2, Julie Reed2.
Abstract
BACKGROUND: Patient and Public Involvement (PPI) strategic documents are viewed as an essential feature of organisational commitment to openness and transparency. They provide a mechanism to communicate opportunities for wider community influence in healthcare. The absence of documentation can be negatively interpreted, for example during regulatory inspection, as a lack of intent by organisations to collaborate with a broad constituency. Published literature paints a confusing picture of rationale and evidence that could provide the foundation for strategic action. This makes it difficult for those responsible for turning goals into meaningful involvement. We investigated how content is presented and organised in strategic documents. This pragmatic study is intended to stimulate reflective practice, promote debate and generate further inquiry with a wide audience.Entities:
Keywords: Action effect method; Framework method; Involvement; Patient; Programme theory; Public; Quality improvement; Strategic
Year: 2019 PMID: 31700675 PMCID: PMC6827253 DOI: 10.1186/s40900-019-0164-0
Source DB: PubMed Journal: Res Involv Engagem ISSN: 2056-7529
Aims: National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC)
• Develop and conduct applied health research relevant across the NHS, and translate research findings into improved outcomes for patients • Create a distributed model for the conduct and application of applied health research that links those who conduct applied health research with all those who use it in practice across the health community • Create and embed approaches to research and its dissemination that are specifically designed to take account of the way that healthcare is delivered across the local Academic Health Science Network • Increase the country’s capacity to conduct high quality applied health research focused on the needs of patients, and particularly research targeted at chronic disease and public health interventions • Improve patient outcomes locally and across the wider NHS; and • contribute to the country’s growth by working with the life sciences industry |
Source: [23]
Source of documents included for final analysis
| Source of documents included for final analysis | ||
|---|---|---|
| Organisation | Group | n |
| Acute Care Providers (includes mental health and tertiary trusts) | A | 4 |
| Clinical Commissioning Groups (CCG) | B | 6 |
| Community Healthcare Providers | C | 1 |
| Other (includes ambulance, research and education) | D | 4 |
| Total | 15 | |
Adapted Analysis Framework using 4Pi National Involvement Standards [19]
| Adapted Analysis Framework using 4Pi National Involvement Standards | ||
|---|---|---|
| 4Pi Domain | Definition used for analysis | Questions to support analysis |
| Principles | • A set of values that inform meaningful involvement | 1. Are values identified? e.g. ‘equality and diversity impact assessments inform our strategy’ 2. Is there evidence that values influence the strategy? 3. Are principles stated? |
| Purpose | • Makes it explicit why people are involved • Describes why people are involved • Provides a rationale/goal for activity | 1. Is there a purpose or aim? 2. Are objectives recorded? |
| Presence | • Describes which groups/people need to be involved to shape and achieve the stated purpose | 1. Who is the strategy author? 2. Who has influenced the strategy? 3. Are target groups/populations identified? 4. Is information available about key contacts/partners? |
| Process | • Describes how involvement will happen • Sets out a series of relevant/appropriate methods or steps to achieve aim/objectives • Indicates opportunity for reflection/learning/evolution over time | 1. Are plans described to achieve the purpose or aim? 2. Are there defined, time bound mechanisms to deliver the strategy? (Who, when, where, how) 3. Are reporting mechanisms in place to provide progress reports to all those involved? 4. Are accountability lines documented up to and including executive level? |
| Impact | • Describes the difference involvement will make (intended/short-medium-long-term) | 1. Is there evidence of success/impact criteria? 2. Are there defined mechanisms to assess impact? 3. Are there defined mechanisms for measurement and/or evaluation? |
Rating assigned to each 4Pi National Involvement Standard Domain [19]
| Rating assigned to each 4Pi National Involvement Standard Domain | ||
|---|---|---|
| Rating | Code | Shared definition used by analysts |
| Unmet | U | • No evidence to address analysis questions |
| Partially met | P | • Ambiguous • Some evidence to address analysis questions • Insufficient explanation and detail |
| Fully met | F | • Clear • Enough evidence to address analysis questions • Sufficient explanation and detail |
Rating assigned to PPI strategic documents by 4Pi domain and organisation
| Rating by 4Pi domain and organisation | |||||
|---|---|---|---|---|---|
| Group/ID | Principles | Purpose | Presence | Process | Impact |
| A1 | F | F | P | P | P |
| A2 | F | P | U | U | P |
| A3 | P | P | P | P | P |
| A4 | U | F | P | P | U |
| B5 | U | P | P | P | U |
| B6 | U | F | U | P | U |
| B7 | F | F | P | P | P |
| B8 | U | U | P | P | U |
| B9 | F | F | F | P | F |
| B10 | U | U | P | P | U |
| C11 | P | F | U | P | F |
| D12 | U | F | P | P | U |
| D13 | U | F | U | U | U |
| D14 | U | P | P | U | P |
| D15 | P | P | P | F | P |
Group A Acute Care Providers (includes mental health and tertiary trusts)
Group B Clinical Commissioning Groups (CCG)
Group C Community Healthcare Providers
Group D Other (includes ambulance, research, and education)
Key: U, Unmet; P, Partially met; F, Fully met
Fig. 1Schematic action effect diagram: guide to interpreting the components and overall structure of a typical action effect diagram [40]